Managing Heart Failure

Introduction.- Risk factors and pathophysiology.- Diagnosis and assessment.- Management strategies in heart failure.- Pharmacological management of heart failure.- Nonpharmacological management of heart failure.- Future directions_

John George Franklin Cleland Professor of Cardiology, University of Hull, UK Professor John Cleland qualified in medicine at the University of Glasgow, Scotland in 1977. After a period of postgraduate training and an introduction to research he was appointed first a Senior Registrar and subsequently as Senior Lecturer in Cardiology and Honorary Consultant Cardiologist at St Mary's Hospital, Paddington and the Hammersmith Hospital, London from 1986-1994. In 1994 Professor Cleland was awarded a Senior Research Fellowship by the British Heart Foundation to transfer to the Medical Research Council's Clinical Research Initiative in Heart Failure. Professor Cleland was appointed to the Foundation Chair of Cardiology at the University of Hull in 1999. Professor Cleland's main field of interest is in heart failure, extending from its epidemiology and prevention, through the development and implementation of guidelines for the application of current knowledge, to large randomised trials to study interventions for and disease areas in heart failure. Particular current interests include the role of myocardial hibernation contributing to heart failure and its treatment (including beta-blockers and revascularisation), diastolic heart failure in the elderly, the potential deleterious effect of aspirin in heart failure, ventricular resynchronisation, telemonitoring, implantable haemodynamic monitoring devices, atrial fibrillation in heart failure and new interventions for acute decompensated heart failure.